The Combination of CK19 and KIT is a Potential Predictor for Clinical Behaviors and Postoperative Outcomes in Resectable Pancreatic Neuroendocrine Tumors

#593

Introduction: We assumed that pNETs is a disease triggered by the re-activation of developmental signaling pathways, once again expressing KIT and CK19.

Aim(s): We validate the expressions of CK19 and KIT in normal pancreatic islets and resectable pancreatic neuroendocrine tumors (pNETs).

Materials and methods: Immunohistochemistry (ICH) was performed.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Han X, Zhao J, Ji Y, Xu X, Lou W,

Keywords: pNET, CK19, KIT,

To read the full abstract, please log into your ENETS Member account.